16523403|t|Neramexane (merz pharmaceuticals/forest laboratories).
16523403|a|Merz Pharmaceuticals GmbH and Forest Laboratories Inc are developing neramexane, an oral N-methyl-D-aspartate antagonist, as a potential neuroprotectant for various central nervous system disorders, including Alzheimer's disease, and for the potential treatment of drug and alcohol dependence, and pain.
16523403	0	10	Neramexane	Chemical	MESH:C114144
16523403	12	32	merz pharmaceuticals	Chemical	-
16523403	55	75	Merz Pharmaceuticals	Chemical	-
16523403	124	134	neramexane	Chemical	MESH:C114144
16523403	228	252	nervous system disorders	Disease	MESH:D009422
16523403	264	283	Alzheimer's disease	Disease	MESH:D000544
16523403	320	347	drug and alcohol dependence	Disease	MESH:D019966
16523403	353	357	pain	Disease	MESH:D010146
16523403	Negative_Correlation	MESH:C114144	MESH:D009422
16523403	Negative_Correlation	MESH:C114144	MESH:D000544
16523403	Negative_Correlation	MESH:C114144	MESH:D010146
16523403	Negative_Correlation	MESH:C114144	MESH:D019966

